Skip to main content

Crispr Therapeutics Ag(CRSP-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Crispr Therapeutics Ag

BAARERSTRASSE 14
ZUG V8 CH-6300 CHE
P: 41-41-561-3277
http://www.crisprtx.com

Profile

CRISPR Therapeutics AG is a leading gene editing company focused on developing CRISPR/Cas9-based therapeutics. The company is rapidly leveraging its CRISPR/Cas9 gene-editing platform to make therapies for the treatment of hemoglobinopathies, cancer, diabetes and other diseases.

Key Executives

NameTitle
Samarth KulkarniCEO/Chairman of the Board/Director
Raju PrasadCFO/Chief Administrative Officer

More from The Globe